Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer
Status:
Unknown status
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
A multi-center, non-random, open study ,to observe efficacy and safety of bevacizumab plus
Oxaliplatin based multidrug chemotherapy as conversion therapy for patients with previously
untreated unresectable liver metastases from colorectal cancer.